Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adetunji T Toriola

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
JAMA Health Forum|September 27, 2024
Menopausal Hormone Therapy Use Among Postmenopausal WomenLin Yang, Adetunji T Toriola
Breast Cancer Research : BCR|February 3, 2026
Generational trends in reproductive factors among women in the US: implications for breast cancer incidenceLin Yang, Adetunji T Toriola
Obesity (Silver Spring, Md.)|November 1, 2017
Inflammation Modifies the Association of Obesity with Circulating 25-Hydroxyvitamin D Levels in Cancer SurvivorsLin Yang, Adetunji T Toriola
BMJ Open|July 13, 2017
Leisure-time physical activity and circulating 25-hydroxyvitamin D levels in cancer survivors: a cross-sectional analysis using data from the US National Health and Nutrition Examination SurveyLin Yang, Adetunji T Toriola
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2024
The Untapped Opportunities of Addressing Lifecourse Growth in Mammographic Breast Density and Breast Cancer Prevention in Non-Hispanic Black WomenGhazaleh Pourali, Adetunji T Toriola
Journal of the National Cancer Institute|November 2, 2020
Refining the Focus on Early Life and Adolescent Pathways to Prevent Breast CancerGraham A Colditz, Adetunji T Toriola
JNCI Cancer Spectrum|August 11, 2021
Reply to Hopper, Nguyen, and LiAna S Salazar, Adetunji T Toriola
Future Oncology (London, England)|August 23, 2014
Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected]Adetunji T Toriola, Ryan C Fields
Breast Cancer Research and Treatment|April 3, 2013
Trends in breast cancer incidence and mortality in the United States: implications for preventionAdetunji T Toriola, Graham A Colditz
Future Oncology (London, England)|October 14, 2011
Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?Adetunji T Toriola, Cornelia M Ulrich
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
JAMA Health Forum|September 27, 2024
Menopausal Hormone Therapy Use Among Postmenopausal WomenLin Yang, Adetunji T Toriola
Breast Cancer Research : BCR|February 3, 2026
Generational trends in reproductive factors among women in the US: implications for breast cancer incidenceLin Yang, Adetunji T Toriola
Obesity (Silver Spring, Md.)|November 1, 2017
Inflammation Modifies the Association of Obesity with Circulating 25-Hydroxyvitamin D Levels in Cancer SurvivorsLin Yang, Adetunji T Toriola
BMJ Open|July 13, 2017
Leisure-time physical activity and circulating 25-hydroxyvitamin D levels in cancer survivors: a cross-sectional analysis using data from the US National Health and Nutrition Examination SurveyLin Yang, Adetunji T Toriola
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2024
The Untapped Opportunities of Addressing Lifecourse Growth in Mammographic Breast Density and Breast Cancer Prevention in Non-Hispanic Black WomenGhazaleh Pourali, Adetunji T Toriola
Journal of the National Cancer Institute|November 2, 2020
Refining the Focus on Early Life and Adolescent Pathways to Prevent Breast CancerGraham A Colditz, Adetunji T Toriola
JNCI Cancer Spectrum|August 11, 2021
Reply to Hopper, Nguyen, and LiAna S Salazar, Adetunji T Toriola
Future Oncology (London, England)|August 23, 2014
Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected]Adetunji T Toriola, Ryan C Fields
Breast Cancer Research and Treatment|April 3, 2013
Trends in breast cancer incidence and mortality in the United States: implications for preventionAdetunji T Toriola, Graham A Colditz
Future Oncology (London, England)|October 14, 2011
Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?Adetunji T Toriola, Cornelia M Ulrich
Pageof 15